TD Cowen analyst Joshua Jennings reiterates Senseonics Holdings (NASDAQ:SENS) with a Buy and main

First clinical evaluation of investigational, transmitter-free one-year CGM marks an important miles

First clinical evaluation of investigational, transmitter-free one-year CGM marks an important miles

GERMANTOWN, Md., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medic

GERMANTOWN, Md., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medica

Senseonics Holdings (AMEX:SENS) released second-quarter financial results and hosted an earnings cal

Senseonics is rated Hold due to positive sales growth, margin improvement, and product differentiati

Barclays analyst Christopher Pasquale initiates coverage on Senseonics Holdings (NASDAQ:SENS) wit

Bank of America Corp DE bought a new position in shares of Senseonics Holdings, Inc. Common Stock (N

BBNX's Eversense 365 partnership is likely to broaden CGM choice and strengthen its automated insuli

IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering l

The companies are collaborating to integrate Eversense® 365 CGM with Beta Bionics’ iLet® Bionic Panc

Pairing year-long continuous glucose monitoring with automated insulin delivery to further simplify

GERMANTOWN, Md., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medic

BlackRock Inc. bought a new stake in Senseonics Holdings, Inc. Common Stock (NASDAQ: SENS) in the se

U.S. stock futures mixed, Nasdaq 100 up 0.1%. Coty Inc (COTY) shares down 7.7% after reporting losse

Cramer recommends buying Carpenter Technology (NYSE: CRS) and calls DXC Technology (NYSE: DXC) a val

Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session.

Senseonics Holdings, Inc. Common Stock NASDAQ: SENS raised its full-year 2026 revenue and gross-marg

Senseonics Holdings, Inc. (SENS) Q2 2026 Earnings Call Transcript

Senseonics Holdings (SENS) came out with a quarterly loss of $0.63 per share versus the Zacks Consen

Senseonics Holdings (AMEX:SENS) raises FY2026 sales outlook from $60.000 million-$64.000 million to

Senseonics Holdings (AMEX:SENS) reported quarterly losses of $(0.63) per share which met the analyst

GERMANTOWN, Md., July 21, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medica

Mizuho analyst Anthony Petrone maintains Senseonics Holdings (NASDAQ:SENS) with a Outperform and

Senseonics (SENS) was a big mover last session on higher-than-average trading volume. The latest tre

SENS partners with Welldoc on a next-gen Eversense 365 app, adding Apple Health/Google Health Connec

Senseonics, a medical technology company focused on implantable Continuous Glucose Monitoring (CGM)

Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, valid

Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, valid

Senseonics Holdings, Inc. (SENS) Shareholder/Analyst Call Transcript

GERMANTOWN, Md., June 01, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medic

HC Wainwright & Co. analyst Sean Lee maintains Senseonics Holdings (NASDAQ:SENS) with a Buy a

Stifel analyst Jonathan Block maintains Senseonics Holdings (NASDAQ:SENS) with a Hold and lowers

Senseonics Holdings, Inc. Common Stock NASDAQ: SENS raised its full-year 2026 revenue outlook after

Senseonics Holdings (AMEX:SENS) raises FY2026 sales outlook from $58.000 million-$62.000 million to

Senseonics Holdings (AMEX:SENS) reported quarterly losses of $(0.71) per share which missed the anal

Shares of Senseonics Holdings Inc (NASDAQ:SENS) are tumbling Friday morning pricing an $80 million u

Twilio Inc (NYSE: TWLO) reported strong Q1 results and raised future sales guidance above estimates,

Senseonics Holdings, Inc. (NASDAQ:SENS), a medical technology company focused on the development, ma

GlucoTrack targets a Q2 2026 FDA IDE filing for CGM, backed by clinical data, manufacturing strategy

https://www.sec.gov/Archives/edgar/data/1616543/0001270735-26-000004-index.html

Senseonics Holdings (AMEX:SENS) sees FY2026 sales of $58.000 million-$62.000 million vs $58.832 mill

Senseonics Holdings (AMEX:SENS) reported quarterly losses of $(0.46) per share which missed the anal

Sequel Med Tech, LLC, a company developing transformative drug delivery technologies, and Senseonics